뒤로
Jiangsu Hengrui Pharmaceuticals Co.,Ltd(01276.HK) 가격
01276.HK 주가 차트
HENGRUI PHARMA (01276.HK)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
HK$70.25
0.35%
$0.25
장 종료: Feb 16, 12:00:00 HKT
아직 데이터 없음Follow-Up Questions
Jiangsu Hengrui Pharmaceuticals Co.,Ltd의 주요 재무제표는 무엇인가요?
01276.HK의 주요 재무 비율은 무엇인가요?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd은 수익성이 있나요?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd에 부채가 있나요?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$70.25
시가
$70
일일 범위
$69.2 - $70.25
52주 범위
$52.5 - $95.2
거래량
176.8K
평균 거래량
3.1M
EPS(TTM)
1.31
배당수익률
--
시가총액
$18.0B
HENGRUI PHARMA란 무엇인가요?
Jiangsu Hengrui Pharmaceuticals Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Lianyungang, Jiangsu and currently employs 20,238 full-time employees. The company went IPO on 2000-10-18. Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company mainly engaged in the research, development, production and sales of drugs. The firm focuses on the field of oncology, covering kinase inhibitors, antibody-drug conjugates (ADCs), tumor immunity, hormone receptor regulation, deoxyribonucleic acid (DNA) repair and epigenetics, supportive care and other research areas. The firm's products include anti-tumor, analgesic anesthesia and contrast agents, which are used in autoimmune diseases, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory diseases, blood diseases, pain management, neurological diseases, ophthalmology, nephrology and other fields. The firm mainly conducts its businesses in domestic and foreign markets.